Advertisement

Irish Journal of Medical Science (1971 -)

, Volume 188, Issue 1, pp 267–272 | Cite as

Attitudes of Irish patients with chronic pain towards medicinal cannabis

  • Ciaran Rochford
  • Deirdre Edgeworth
  • Mohammad Hashim
  • Dominic HarmonEmail author
Original Article

Abstract

Background

Medicinal cannabis use is topical in the media in Ireland. A recent Health Products Regulatory Authority review, however, has recommended against its use for patients with chronic pain. This is despite evidence for its effectiveness in this patient’s cohort and the inadequate pain management of these patients.

Aim

The aim of this study was to evaluate the attitudes of Irish patients with chronic pain towards medicinal cannabis.

Methods

After institutional ethics committee approval, a 12-item questionnaire (excluding demographics) was randomly assigned to patients attending a chronic pain clinic (University Hospital Limerick). The questionnaire was designed to incorporate patient’s attitudes on a variety of medicinal cannabis related topics.

Results

Ninety-six adult patients were surveyed. 88.54% agreed that cannabis should be legalised for chronic pain medicinal purposes. 80.21% believed it would have health benefits for them and 73.96% agreed it would be socially acceptable to use cannabis for this purpose. 33.33% perceived cannabis to be addictive while 68.75% would be willing to try it if prescribed by a medical professional.

Conclusions

The study highlights the attitudes of chronic pain patients in Ireland towards medicinal cannabis. It shows their desire to have medical cannabis legalised for chronic pain and that they view it as a reasonable pain management option.

Keywords

Attitudes Cannabis Chronic pain 

Notes

Compliance with ethical standards

The study protocol was approved by the research ethics committee of University Limerick Hospitals Group, Mid-West Region.

Conflict of interest

None.

References

  1. 1.
    Hall W, Degenhardt L (2007) Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 20(4):393–397.  https://doi.org/10.1097/YCO.0b013e32812144cc Google Scholar
  2. 2.
    Bostwick JM (2012) Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc 87(2):172–186.  https://doi.org/10.1016/j.mayocp.2011.10.003 Google Scholar
  3. 3.
    Rehm J, Fischer B (2015) Cannabis legalization with strict regulation, the overall superior policy option for public health. Clin Pharmacol Ther 97(6):541–544.  https://doi.org/10.1002/cpt.93 Google Scholar
  4. 4.
    Van den Brink W (2008) Forum: decriminalization of cannabis. Curr Opin Psychiatry 21(2):122–126.  https://doi.org/10.1097/YCO.0b013e3282f57e04 Google Scholar
  5. 5.
    Department of Health. Minister Harris announces ‘pivotal step’ on Medicinal Cannabis Access Programme [press release]. 2017. [Accessed: 15/12/2017] [Available from: http://health.gov.ie/blog/press-release/minister-harris-announces-pivotal-step-on-medicinal-cannabis-access-programme-prescribers-patients-and-pharmacists-to-draw-up-guidance-for-the-safe-use-of-cannabis-based-treatment/]
  6. 6.
    Health Products Regulatory Authority. Cannabis for medical use—a scientific review 2017 [Accessed: 15/12/2017] [Available from: https://www.hpra.ie/docs/default-source/publications-forms/newsletters/cannabis-for-medical-use---a-scientific-review.pdf?sfvrsn=7]
  7. 7.
    Lynch ME, Ware MA (2015) Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J NeuroImmune Pharmacol 10(2):293–301.  https://doi.org/10.1007/s11481-015-9600-6 Google Scholar
  8. 8.
    Breivik H, Collett B, Ventafridda V et al (2016) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10(4):287–333Google Scholar
  9. 9.
    Khelemsky Y, Goldberg AT, Hurd YL, Winkel G, Ninh A, Qian L, Oprescu A, Ciccone J, Katz DJ (2017) Perioperative patient beliefs regarding potential effectiveness of marijuana (cannabinoids) for treatment of pain: a prospective population survey. Reg Anesth Pain Med 42(5):652–659.  https://doi.org/10.1097/AAP.0000000000000654 Google Scholar
  10. 10.
    Otero MJ, Moreno-Gomez AM, Santos-Ramos B et al (2014) Developing a list of high-alert medications for patients with chronic diseases. Eur J Intern Med 25(10):900–908.  https://doi.org/10.1016/j.ejim.2014.10.021 Google Scholar
  11. 11.
    Williams J, van Ours JC, Grossman M (2016) Attitudes to legalizing cannabis use. Health Econ 25(9):1201–1216.  https://doi.org/10.1002/hec.3340 Google Scholar
  12. 12.
    Single E, Christie P, Ali R (2000) The impact of cannabis decriminalisation in Australia and the United States. J Public Health Policy 21(2):157–186Google Scholar
  13. 13.
    Crowley D, Collins C, Delargy I et al (2017) Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. Harm Reduct J 14(1):4Google Scholar
  14. 14.
    Nussbaum AM, Boyer JA, Kondrad EC (2011) “But my doctor recommended pot”: medical marijuana and the patient-physician relationship. J Gen Intern Med 26(11):1364–1367.  https://doi.org/10.1007/s11606-011-1840-4 Google Scholar
  15. 15.
    Berkovic SF (2017) Cannabinoids for epilepsy—real data, at last. N Engl J Med 376(21):2075–2076.  https://doi.org/10.1056/NEJMe1702205 Google Scholar
  16. 16.
    Hall W, Degenhardt L (2009) Adverse health effects of non-medical cannabis use. Lancet 374(9698):1383–1391.  https://doi.org/10.1016/S0140-6736(09)61037-0 Google Scholar
  17. 17.
    Barry MJ, Edgman-Levitan S (2012) Shared decision making—pinnacle of patient-centered care. N Engl J Med 366(9):780–781.  https://doi.org/10.1056/NEJMp1109283 Google Scholar
  18. 18.
    Kondrad E, Reid A (2013) Colorado family physicians’ attitudes toward medical marijuana. J Am Board Fam Med 26(1):52–60.  https://doi.org/10.3122/jabfm.2013.01.120089 Google Scholar
  19. 19.
    Kleber HD, DuPont RL (2012) Physicians and medical marijuana. Am J Psychiatry 169(6):564–568.  https://doi.org/10.1176/appi.ajp.2012.12030373 Google Scholar
  20. 20.
    Grant I, Atkinson JH, Gouaux B, Wilsey B (2012) Medical marijuana: clearing away the smoke. Open Neurol J 6(1):18–25.  https://doi.org/10.2174/1874205X01206010018 Google Scholar
  21. 21.
    Kahan M, Srivastava A, Spithoff S et al (2014) Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations. Can Fam Physician 60(12):1083–1090Google Scholar
  22. 22.
    Serpell M, Ratcliffe S, Hovorka J et al (2014) A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain 18(7):999–1012Google Scholar
  23. 23.
    Bostwick JM, Reisfield GM, DuPont RL (2013) Clinical decisions. Medicinal use of marijuana. N Engl J Med 368(9):866–868.  https://doi.org/10.1056/NEJMclde1300970 Google Scholar
  24. 24.
    Jones RT, Benowitz NL, Herning RI (1981) Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21 (8–9 Suppl):143s–152sGoogle Scholar
  25. 25.
    Barrett P, Bradley C (2016) Attitudes and perceived risk of cannabis use in Irish adolescents. Ir J Med Sci 185(3):643–647.  https://doi.org/10.1007/s11845-015-1325-2 Google Scholar
  26. 26.
    Broyd SJ, van Hell HH, Beale C, Yucel M, Solowij N (2016) Acute and chronic effects of cannabinoids on human cognition—a systematic review. Biol Psychiatry 79(7):557–567.  https://doi.org/10.1016/j.biopsych.2015.12.002 Google Scholar
  27. 27.
    Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M et al (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370(9584):319–328Google Scholar
  28. 28.
    Vicente J, Wiessing L (2007) European Monitoring Centre for Drugs and Drug Addiction annual report 2007: positive assessment of HIV in IDUs though hepatitis C still very high. Euro Surveill 12(11):E071122.6Google Scholar
  29. 29.
    Menghrajani P, Klaue K, Dubois-Arber F et al (2005) Swiss adolescents’ and adults’ perceptions of cannabis use: a qualitative study. Health Educ Res 20(4):476–484Google Scholar
  30. 30.
    Colorado Department of Public Health and Environment. The Colorado Medical Marijuana Registry 2017. [Accessed 15/12/2017] [Available from: https://www.colorado.gov/pacific/cdphe/2017-medical-marijuana-registry-statistics]
  31. 31.
    Russo EB, Guy GW, Robson PJ (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4(8):1729–1743.  https://doi.org/10.1002/cbdv.200790150 Google Scholar
  32. 32.
    Whiting PF, Wolff RF, Deshpande S, di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J (2015) Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313(24):2456–2473.  https://doi.org/10.1001/jama.2015.6358 Google Scholar
  33. 33.
    Lynch ME (2011) The need for a Canadian pain strategy. Pain Res Manag n 16(2):77–80.  https://doi.org/10.1155/2011/654651 Google Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2018

Authors and Affiliations

  • Ciaran Rochford
    • 1
  • Deirdre Edgeworth
    • 2
  • Mohammad Hashim
    • 2
  • Dominic Harmon
    • 1
    Email author
  1. 1.Graduate Entry Medical SchoolUniversity of LimerickLimerickIreland
  2. 2.Department of Anesthesia and Pain MedicineLimerick University HospitalLimerickIreland

Personalised recommendations